Clinical utility of the triglyceride–glucose index in assessing metabolic dysregulation among pulmonary tuberculosis patients
Tuberculosis (TB) remains a major global health burden, particularly in resource-limited settings. Our cross-sectional study, conducted at a tertiary care hospital in Delhi (September 2022-February 2024), evaluated 130 newly diagnosed pulmonary TB patients to assess the utility of the triglyceride-glucose (TyG) index as a screening tool for insulin resistance and metabolic dysregulation in pulmonary tuberculosis patients. Diabetes was present in 26.2% of participants. The TyG index demonstrated strong positive correlations with HbA1c in both diabetic and non-diabetic groups. It was significantly associated with microbiological severity indicators, including sputum grading, culture positivity time and Ct values. Receiver operating characteristic analysis showed excellent diagnostic performance for detecting diabetes, with a cut-off ≥4.895 achieving 100% sensitivity and 94% specificity. Overall, the TyG index emerges as a simple, cost-effective marker for early identification of metabolic derangement and disease severity in pulmonary TB, supporting its potential role in screening in low-resource settings.
Authors
- Puneeta Hyanki
- Bineeta Kashyap (ORCID: https://orcid.org/0000-0003-2471-4078)
- Debamita Banik (ORCID: https://orcid.org/0009-0001-9916-9687)
Institutions
- University College of Medical Sciences (IN)
- Guru Teg Bahadur Hospital (IN)
Publication Details
- Journal
- Tropical Doctor
- Published
- 2026-11-17
- DOI
- https://doi.org/10.1177/00494755261508886
- Primary Topic
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Type
- article
- Field-Weighted Citation Impact
- 0.00